Clinical efficacy of specific immunotherapy to cat dander: A double- blind placebo-controlled trial

Clinical and Experimental Allergy

Volumn 27, Issue 8, 1997, Pages 860-867

  Varney, V A ^a   Edwards, J ^a   Tabbah, K ^a   Brewster, H ^a   Mavroleon, G ^a   Frew, A J ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Immunotherapy cat clinical trial

Indexed keywords

ALLERGY; ARTICLE; ASTHMA; CAT; CLINICAL ARTICLE; CLINICAL TRIAL; DANDER; HUMAN; PRIORITY JOURNAL; RHINOCONJUNCTIVITIS; SKIN SENSITIVITY; TREATMENT OUTCOME;

ADULT; ALLERGENS; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; ASTHMA; CATS; CONJUNCTIVITIS, ALLERGIC; DESENSITIZATION, IMMUNOLOGIC; DOUBLE-BLIND METHOD; ENGLAND; FEMALE; GLYCOPROTEINS; HUMANS; MALE; MIDDLE AGED; MITES; PLACEBOS; SKIN; SKIN TESTS; TREATMENT OUTCOME;

EID: 0030871984     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.1997.tb01225.x     Document Type: Article

References (20)

1. Wood RA, Chapman MD, Adkinson NF, Eggleston PA. The effect of cat removal on allergen content in household dust samples. J Allergy Clin Immunol 1989; 83:730-4.
2. Munir AKM, Einarsson R, Schou C, Dreborg SKG. Allergens in school dust. I The amount of major cat (Fel d1) and dog (Can f1) allergen in dust from Swedish schools is high enough to probably cause perennial symptoms in most children with asthma who are sensitised to cat and dog. J Allergy Clin Immunol 1993; 91:1067-74.
3. Bollinger ME, Eggleston PA, Flanagan E, Wood RA. Cat antigen in homes with and without cats may induce allergic symptoms. J Allergy Clin Immunol 1996; 97:907-14.
4. Berrens L, Maranon F. Enzymatic properties of cat allergen I. (Fel dI). Clin Exp Allergy 1990; 20:S1 (:0P6).
5. Wentz P, Swanson M, Reed C. Variability of cat allergen shedding. J Allergy Clin Immunol 1990; 85:94-8.
6. Taylor WW, Ohman JL, Lowell FC. Immunotherapy in cat-induced asthma. Double-blind trial with evaluation of bronchial responses to cat allergen and histamine. J Allergy Clin Immunol 1978; 61:283-7.
7. Ohman JL, Findlay SR, Leitermann KM. Immunotherapy in cat-induced asthma. Double blind trial with evaluation of in vivo and in vitro responses. J Allergy Clin Immunol 1984; 74:230-9.
8. Sundin B, Lilja G, Graff-Lonnevig V et al. Immunotherapy with partially purified and standardised animal dander extracts. I Clinical results from a double-blind study on patients with an animal dander asthma. J Allergy Clin Immunol 1986; 77:478-87.
9. Alvarez-Cuesta E, Cuesta-Herranz J, Puyana-Ruiz J et al. Monoclonal antibody-standardized cat extract immunotherapy: risk-benefit effects from a double-blind placebo study. J Allergy Clin Immunol 1994; 93:556-66.
10. Malling H-J. Proposed guidelines for quantitative skin prick test procedures to determine the biological activity of allergenic extracts using parallel line assay. Allergy 1987; 42:391-4.
11. Möller C, Björkstén B, Nilsson G, Dreborg S. The precision of the conjunctival provocation test. Allergy 1984; 39:37-41.
12. Lilja G, Sundin B, Graff-Lonnevig V et al. Immunotherapy with partially purified and standardised animal dander extracts. IV Effects of 2 years of treatment. J Allergy Clin Immunol 1989; 83:37-44.
13. Hedlin G, Graff-Lonnevig V, Heilborn H et al. Immunotherapy with partially purified and standardised animal dander extracts. II In vivo and in vitro effects observed in 1 year double-blind placebo study. J Allergy Clin Immunol 1986; 77:488-96.
14. Löwenstein H, Graff-Lonnevig V, Hedlin G et al. Immunotherapy with partially purified and standardised animal dander extracts. III Allergen-specific immunoglobulin responses in a 1 year double-blind placebo study. J Allergy Clin Immunol 1986; 77:497.
15. Wood RA, Laheri AN, Eggleston PA. The aerodynamic characteristics of cat allergen. Clin Exp Allergy 1993; 23:733-9.
16. Varney VA, Hamid QA, Gaga M et al. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. J Clin Invest 1993; 92:644-51.
17. McHugh SM, Deighton J, Stewart AG, Lachman PJ, Ewan PW. Bee venom immunotherapy induces a shift in cytokine responses from a Th2 to a Th1 dominant pattern: comparison of rush and conventional immunotherapy. Clin Exp Allergy 1995; 25:828-38.
18. Thompson-Snipes L, Dhar V, Bond MW et al. Interleukin-10: a novel stimulatory factor for mast cells and their progenitors. J Exp Med 1991; 173:507-10.
19. Robinson DS, Tsicopoulos A, Meng Q et al. Increased IL-10 messenger RNA expression in atopic allergy and asthma. Am J Respir Cell Mol Biol 1996; 14:113-17.
20. Powrie F, Coffman RL. Cytokine regulation of T-cell function: potential for therapeutic intervention. Immunol Today 1993; 14:270-4.